News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
The Role of Proactive Monitoring Solutions in the Shift to a Risk-Based Care Model - MedCity News
More effective and proactive care requires a framework that will enable the U.S. healthcare system to better meet the inevitable challenges of an aging population and pave the way for a sustainable and equitable future. Monitoring and other digital health enabled tools are helping to build that framework by offering a new medium for care delivery that can supplement primary care and care management services.
Open Source Healthcare - The Cure for Stagnant Medical Innovation - MedCity News
We are living in a moment when many realize that collaboration yields better, faster and more affordable advances. Open source also enables the potential for bigger profits and revenue. What’s in reach: a small amount of money paid for treatments across millions of people, rather than expensive lifesaving treatments only for the few who can afford them.
Vertex Pharma’s Opioid Alternative Wins FDA Approval, First in a New Class of Pain Meds - MedCity News
Vertex Pharmaceuticals’ Jounavx is now FDA approved, providing patients a non-opioid option for treating acute pain. The twice-daily pill is the first in a new class of medicines that block a key pathway in the peripheral nervous system.
MedCity FemFwd: Comparing Maternal Health in Employer-Sponsored Populations vs. Medicaid - MedCity News
In this episode, we’re joined by Emily Lindemer, an executive director at Morgan Health. Lindemer discusses a recent report she co-authored, which focuses on maternal health opportunities in employer-sponsored insurance.
The Most Overlooked Feature with AI Scribes: Coding Awareness - MedCity News
By insisting on coding-aware AI solutions, health systems can ensure that these technologies fulfill their transformative promise, reducing clinician burnout and administrative burden, improving patient care and communication, and accurately capturing what occurred during an encounter.
Telehealth Clinic Hone Health Secures $33M, Acquires Home Health Company - MedCity News
Hone Health's Series A round included participation from Tribe Capital, PIF, Republic Capital, Vibe VC, Humbition, Hanwha, Gaingels, Looking Glass Capital, FJ Labs and Agent Capital. In total, the company has raised $39 million.
Safety Risk Sinks Cargo Therapeutics’ Cancer Cell Therapy Prospect, Leading to 50% Staff Cut - MedCity News
Phase 2 data for Cargo Therapeutics’ CD22-targeting cell therapy show low durability and cases of a severe immune response, some that were classified as grade 4 or 5 serious adverse events. Cargo is discontinuing the study and shifting focus to a different cell therapy on track to begin Phase 1 testing in mid-2025.
Why Blood is Best: Transforming the Diagnostic Journey for Alzheimer's Disease - MedCity News
As the pool of approved therapies continues to (hopefully) expand, the clinical and diagnostic testing communities need to do a better job at ensuring the right patients move through this journey more quickly – and accurately – to improve their health and prognosis.
From Admission to Discharge: How AI Reduces Hospital Length of Stay - MedCity News
Implementing patient flow technology ultimately enhances operational efficiency and improves the overall patient experience, making it essential for healthcare organizations aiming for better outcomes, improved capacity management, and greater financial stability.
You Have to Spend Money to Make Money — Impacts of the NIH Freeze, from Global Economics to My Own Childcare Arrangements - MedCity News
As President Trump would have most certainly learned on his first day at Wharton, you really have to spend money to make money. If you want to make America truly a world leader, why on earth would you stifle the institution that contributed an estimated $92.89 billion to the US economy in 2023 alone and has produced over 170 Nobel Laureates since its inception?
RNAi Biotech Atalanta Unveils $97M to Reach the Clinic in Two Rare Neuro Diseases - MedCity News
The structure of Atalanta Therapeutics’ RNA interference drugs enables them to distribute broadly and deeply into brain tissue. Lead programs for Huntington’s disease and a rare inherited form epilepsy are on track to enter the clinic this year.
Many Community Pharmacists Won’t Carry Drugs in Medicare Negotiation Program, NCPA Warns - MedCity News
According to the National Community Pharmacists Association, 60.4% of independent pharmacists are weighing not stocking one or more of the first 10 drugs in the Medicare Drug Price Negotiation program. Another 32.8% have already decided not to stock one or more of the drugs.
Medtech Startup Quibim Corrals $50M to Advance AI Analysis in Medical Imaging - MedCity News
Quibim’s technology applies artificial intelligence analysis to medical images to detect biomarkers. Hospitals and biopharma companies are among the startup’s customers, using its technology to analyze images to detect disease and guide clinical trial enrollment.
We Need to Talk About Hospice - MedCity News
It's a place where compassion and dignity are paramount, where patients and families find solace and support during the most challenging times. We owe it to them to ensure that hospice care is of the highest quality, accessible to all and integrated into the broader continuum of care.
Akero Smashes Expectations in MASH, Showing Its Drug Reverses Fibrosis in Fatty Livers - MedCity News
Akero Therapeutics reported that at 96 weeks, 39% of patients who received the 50 mg dose of efruxifermin achieved improvement in fibrosis, or liver scarring, caused by the fatty liver disease MASH. This study previously failed to achieve statistically significant improvement at 36 weeks, but Akero executives say the latest results show that longer dosing matters.
5 Critical Lessons from Year One of Hybrid Measure Submissions - MedCity News
The transition to hybrid measures in 2024 has been more than just a regulatory requirement — it's been a catalyst for meaningful change in how we approach quality reporting. Here are five critical insights that can help healthcare organizations comply with requirements and excel in their quality reporting journey.
Novo Nordisk Obesity Drug Shows 22% Weight Loss, But Lack of Safety Detail Is a Sticking Point - MedCity News
Novo Nordisk’s amycretin is a single molecule designed to bind to two targets to spark weight loss — a different approach than some of the pharma giant’s other efforts to develop next-generation obesity drugs. Analysts say the lack of safety and tolerability details make it difficult to fully assess the preliminary Phase 1b/2a results.
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs - MedCity News
January has seen a slew of executive hires, promotions and layoffs across the healthcare industry. For example, health tech companies like Medtronic and athenahealth hired new C-suite leaders, and providers like Cleveland Clinic and Jefferson Health announced rounds of job cuts.
The Keys to Better Mental Healthcare in 2025? Precision, Personalization, and Progress - MedCity News
We now have the ability to diagnose and treat with data-driven insights and deliver measurable outcomes. It’s on us as providers to ensure that we are consistently adopting the latest, proven technology and treatment modalities that can benefit our patients.
Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World - MedCity News
Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced cases of certain blood cancers. Takeda holds an exclusive option to develop and commercialize one of those drugs in most of the world.
Why Sentara Health Invested $11M Into iPhones for Nurses - MedCity News
Sentara Health invested $11 million into smartphones for its nurses, equipping them with HIPAA-compliant devices to streamline communication, increase time at the bedside and improve patient outcomes. The program has been going on for a little more than a year — and Amy Rosa, the health system’s chief nursing informatics officer, says the initiative is already resulting in increased efficiency, documentation accuracy and patient safety.
Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More - MedCity News
Astellas Pharma still looks to grow in cancer with a pipeline that includes internally developed programs that could stand out in oncology. But the drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer Tadaaki Taniguci said.